Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

OCS

Oculis (OCS)

Oculis Holding AG

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:OCS

1

Data	Hora	Fonte	Título	Código	Companhia
26/04/2023	08:00	GlobeNewswire Inc.	Oculis Opens New Offices in the US and Expands its US Team by Appointing Dr. Fang Li as Senior Vice President, Regulatory Affairs	NASDAQ:OCS	Oculis Holding AG
05/04/2023	08:00	GlobeNewswire Inc.	Oculis to Participate at Upcoming Investor Conferences	NASDAQ:OCS	Oculis Holding AG
04/04/2023	08:00	GlobeNewswire Inc.	Oculis to Host Conference Call on April 13, 2023 to Discuss Late-Stage Pipeline and Near-Term Clinical Milestones	NASDAQ:OCS	Oculis Holding AG
22/03/2023	08:00	GlobeNewswire Inc.	Oculis to Ring Nasdaq Stock Market Opening Bell in Celebration of its Successful Listing	NASDAQ:OCS	Oculis Holding AG
16/03/2023	10:45	GlobeNewswire Inc.	Oculis Completes Enrollment in Phase 3 OCS-01 OPTIMIZE Trial	NASDAQ:OCS	Oculis Holding AG
13/03/2023	17:10	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:OCS	Oculis Holding AG